Axel Bolte is the founder of Inozyme. Inozyme has raised $116M in total funding. Latest round: Series A. Based in Cambridge, United States.
Axel Bolte is the co-founder, President, and CEO of Inozyme Pharma, a biotechnology company founded in 2016 in Cambridge, Massachusetts. He led the company through several financing rounds before its acquisition by BioMarin Pharmaceutical in May 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library